Active Ingredient: SOLRIAMFETOL HYDROCHLORIDE
Proprietary Name: SUNOSI
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 150MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N211230
Product Number: 002
Approval Date: Jun 17, 2019
Applicant Holder Full Name: AXSOME MALTA LTD
Marketing Status:
Prescription
Patent and Exclusivity Information
